Loading insider details...
Latest Form 4 (Aug 21, 2026): Grant/Award of 175,000 NMRA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 21, 2026 | Neumora Therapeutics, Inc. (NMRA) | Grant/Award | 175,000 | n/a |
| Feb 19, 2026 | Neumora Therapeutics, Inc. (NMRA) | Sale | 1,436 | $5.1K |
| Jan 9, 2026 | Neumora Therapeutics, Inc. (NMRA) | Grant/Award | 350,000 | n/a |
| May 30, 2025 | Neumora Therapeutics, Inc. (NMRA) | Disposition to Issuer | 85,391 | n/a |
| Feb 20, 2025 | Neumora Therapeutics, Inc. (NMRA) | Sale | 1,978 | $3.4K |
| Feb 18, 2025 | Neumora Therapeutics, Inc. (NMRA) | Grant/Award | 400,000 | n/a |
| Feb 16, 2024 | Neumora Therapeutics, Inc. (NMRA) | Grant/Award | 20,625 | n/a |